Physician profile
Scott Laborwit
NPI 1407933310
$204,238.84
in general payments reported to CMS, 2019-2025
14 companies · $65K in 2025
The $65K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $19.40 · 2021: $13K · 2022: $13K · 2023: $48K · 2024: $65K · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $136K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Travel and Lodging: $8,005 · Food and Beverage: $6,651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $135,776.30 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,500.00 |
| Travel and Lodging | $8,005.18 |
| Food and Beverage | $6,651.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $173,275.26 | 2019-2025 | Lensx, Hydrus Microstent, Ora System Verifeye |
| Alcon Research LLC | $15,470.84 | 2021-2025 | Ngenuity, Lensx |
| Rayner Intraocular Lenses Limited | $4,777.50 | 2025 | Omidria |
| Rxsight INC | $3,835.06 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Lensar, INC. | $3,025.52 | 2022-2024 | Lensar Laser System |
| Sight Sciences, INC. | $2,772.63 | 2021-2023 | Omni Surgical System |
| Ivantis, INC | $500.00 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $216.37 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $209.92 | 2023-2025 | Idosetr, Istent Trabecular Micro-Bypass System Model Is3, Idose |
| Carl Zeiss Meditec, INC. | $69.56 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $26.09 | 2024 | Tecnis Simplicity |
| Kala Pharmaceuticals, INC. | $23.01 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Harrow Eye, LLC | $17.68 | 2025 | Triesence |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Laborwit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.